Cargando…
Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats
BACKGROUND AND PURPOSE: EEG studies show that 5-HT is involved in regulation of sleep–wake state and modulates cortical oscillations. Vortioxetine is a 5-HT(3), 5-HT(7), and 5-HT(1D) receptor antagonist, 5-HT(1B) partial agonist, 5-HT(1A) agonist, and 5-HT transporter inhibitor. Preclinical (animal)...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241092/ https://www.ncbi.nlm.nih.gov/pubmed/24846338 http://dx.doi.org/10.1111/bph.12782 |
_version_ | 1782345815331700736 |
---|---|
author | Leiser, S C Pehrson, A L Robichaud, P J Sanchez, C |
author_facet | Leiser, S C Pehrson, A L Robichaud, P J Sanchez, C |
author_sort | Leiser, S C |
collection | PubMed |
description | BACKGROUND AND PURPOSE: EEG studies show that 5-HT is involved in regulation of sleep–wake state and modulates cortical oscillations. Vortioxetine is a 5-HT(3), 5-HT(7), and 5-HT(1D) receptor antagonist, 5-HT(1B) partial agonist, 5-HT(1A) agonist, and 5-HT transporter inhibitor. Preclinical (animal) and clinical studies with vortioxetine show positive impact on cognitive metrics involving cortical function. Here we assess vortioxetine's effect on cortical neuronal oscillations in actively awake rats. EXPERIMENTAL APPROACH: Telemetric EEG recordings were obtained with the following treatments (mg·kg(−1), s.c.): vehicle, vortioxetine (0.1, 1.0, 3.0, 10), 5-HT(1A) agonist flesinoxan (2.5), 5-HT(3) antagonist ondansetron (0.30), 5-HT(7) antagonist SB-269970-A (10), escitalopram (2.0), duloxetine (10) and vortioxetine plus flesinoxan. Target occupancies were determined by ex vivo autoradiography. KEY RESULTS: Vortioxetine dose-dependently increased wakefulness. Flesinoxan, duloxetine, ondansetron, but not escitalopram or SB-269970-A increased wakefulness. Quantitative spectral analyses showed vortioxetine alone and with flesinoxan increased θ (4–8 Hz), α (8–12 Hz) and γ (30–50 Hz) power. Duloxetine had no effect on θ and γ, but decreased α power, while escitalopram produced no changes. Ondansetron and SB-269970 (≈31–35% occupancy) increased θ power. Flesinoxan (≈41% occupancy) increased θ and γ power. CONCLUSIONS AND IMPLICATIONS: Vortioxetine increased wakefulness and increased frontal cortical activity, most likely because of its 5-HT(7) and 5-HT(3) antagonism and 5-HT(1A) agonism. Vortioxetine differs from escitalopram and duloxetine by increasing cortical θ, α and γ oscillations. These preclinical findings suggest a role of vortioxetine in modulating cortical circuits known to be recruited during cognitive behaviours and warrant further investigation as to their clinical impact. |
format | Online Article Text |
id | pubmed-4241092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42410922015-01-15 Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats Leiser, S C Pehrson, A L Robichaud, P J Sanchez, C Br J Pharmacol Research Papers BACKGROUND AND PURPOSE: EEG studies show that 5-HT is involved in regulation of sleep–wake state and modulates cortical oscillations. Vortioxetine is a 5-HT(3), 5-HT(7), and 5-HT(1D) receptor antagonist, 5-HT(1B) partial agonist, 5-HT(1A) agonist, and 5-HT transporter inhibitor. Preclinical (animal) and clinical studies with vortioxetine show positive impact on cognitive metrics involving cortical function. Here we assess vortioxetine's effect on cortical neuronal oscillations in actively awake rats. EXPERIMENTAL APPROACH: Telemetric EEG recordings were obtained with the following treatments (mg·kg(−1), s.c.): vehicle, vortioxetine (0.1, 1.0, 3.0, 10), 5-HT(1A) agonist flesinoxan (2.5), 5-HT(3) antagonist ondansetron (0.30), 5-HT(7) antagonist SB-269970-A (10), escitalopram (2.0), duloxetine (10) and vortioxetine plus flesinoxan. Target occupancies were determined by ex vivo autoradiography. KEY RESULTS: Vortioxetine dose-dependently increased wakefulness. Flesinoxan, duloxetine, ondansetron, but not escitalopram or SB-269970-A increased wakefulness. Quantitative spectral analyses showed vortioxetine alone and with flesinoxan increased θ (4–8 Hz), α (8–12 Hz) and γ (30–50 Hz) power. Duloxetine had no effect on θ and γ, but decreased α power, while escitalopram produced no changes. Ondansetron and SB-269970 (≈31–35% occupancy) increased θ power. Flesinoxan (≈41% occupancy) increased θ and γ power. CONCLUSIONS AND IMPLICATIONS: Vortioxetine increased wakefulness and increased frontal cortical activity, most likely because of its 5-HT(7) and 5-HT(3) antagonism and 5-HT(1A) agonism. Vortioxetine differs from escitalopram and duloxetine by increasing cortical θ, α and γ oscillations. These preclinical findings suggest a role of vortioxetine in modulating cortical circuits known to be recruited during cognitive behaviours and warrant further investigation as to their clinical impact. Blackwell Publishing Ltd 2014-09 2014-08-28 /pmc/articles/PMC4241092/ /pubmed/24846338 http://dx.doi.org/10.1111/bph.12782 Text en © 2014 The British Pharmacological Society |
spellingShingle | Research Papers Leiser, S C Pehrson, A L Robichaud, P J Sanchez, C Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats |
title | Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats |
title_full | Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats |
title_fullStr | Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats |
title_full_unstemmed | Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats |
title_short | Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats |
title_sort | multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative eeg study in rats |
topic | Research Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241092/ https://www.ncbi.nlm.nih.gov/pubmed/24846338 http://dx.doi.org/10.1111/bph.12782 |
work_keys_str_mv | AT leisersc multimodalantidepressantvortioxetineincreasesfrontalcorticaloscillationsunlikeescitalopramandduloxetineaquantitativeeegstudyinrats AT pehrsonal multimodalantidepressantvortioxetineincreasesfrontalcorticaloscillationsunlikeescitalopramandduloxetineaquantitativeeegstudyinrats AT robichaudpj multimodalantidepressantvortioxetineincreasesfrontalcorticaloscillationsunlikeescitalopramandduloxetineaquantitativeeegstudyinrats AT sanchezc multimodalantidepressantvortioxetineincreasesfrontalcorticaloscillationsunlikeescitalopramandduloxetineaquantitativeeegstudyinrats |